CASI Pharmaceuticals (CASI) News Today $1.33 +0.03 (+2.23%) Closing price 03:55 PM EasternExtended Trading$1.33 +0.00 (+0.08%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CASI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CASI Pharmaceuticals Inc Valuation - MorningstarJuly 2, 2025 | morningstar.comMCASI Pharmaceuticals to divest Chinese assets in $20 million dealMay 12, 2025 | msn.comCasi Pharmaceuticals price target lowered to $4 from $6 at H.C. WainwrightApril 10, 2025 | markets.businessinsider.comCASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely BullishApril 3, 2025 | msn.comCASI Pharmaceuticals Full Year 2024 Earnings: US$2.56 loss per share (vs US$2.02 loss in FY 2023)April 2, 2025 | finance.yahoo.comThis CASI Pharmaceuticals Insider Increased Their Holding By 65% Last YearFebruary 6, 2025 | finance.yahoo.comCASI Pharmaceuticals Third Quarter 2024 Earnings: Beats ExpectationsNovember 17, 2024 | finance.yahoo.comCasi Pharmaceuticals reports Q3 EPS (55c) vs. (35c) last yearNovember 16, 2024 | markets.businessinsider.comCASI Pharmaceuticals’ Mixed Third-Quarter Performance in 2024November 16, 2024 | markets.businessinsider.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Price Passes Above 200 Day Moving Average - Here's What HappenedNovember 9, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Crosses Above 200 Day Moving Average - Here's WhyNovember 1, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average - Should You Sell?October 24, 2024 | marketbeat.comCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest UpdateOctober 16, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above 200-Day Moving Average - Should You Sell?October 10, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Stock, Short Interest ReportOctober 2, 2024 | benzinga.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average of $4.67October 2, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past weekSeptember 28, 2024 | finance.yahoo.comBioInvent International AB (BIX0.DU)September 24, 2024 | sg.finance.yahoo.comCASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.60September 24, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above 200 Day Moving Average of $4.57September 14, 2024 | marketbeat.comCASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCESeptember 4, 2024 | prnewswire.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.46August 27, 2024 | marketbeat.comShort Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 6.9%August 19, 2024 | marketbeat.comCASI Pharmaceuticals, Inc. Q2 Loss DeclinesAugust 17, 2024 | markets.businessinsider.comCASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTSAugust 16, 2024 | prnewswire.comCASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above Two Hundred Day Moving Average of $4.47August 13, 2024 | marketbeat.comLigand Reports Second Quarter 2024 Financial ResultsAugust 6, 2024 | finance.yahoo.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.44August 3, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.comAugust 3, 2024 | marketbeat.com3 Promising Biotech Stocks You Can Pick Up for Less Than $10July 29, 2024 | investorplace.comCASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200 Day Moving Average of $4.41July 26, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Analysts at StockNews.comJuly 26, 2024 | marketbeat.comCASI Pharmaceuticals, Inc.: CASI Pharmaceuticals Reports Development Relating To Its Disputes With JuventasJuly 20, 2024 | finanznachrichten.deCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTASJuly 19, 2024 | prnewswire.comCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Up 771.1% in JuneJuly 11, 2024 | marketbeat.comCASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.42July 10, 2024 | marketbeat.comCASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVPJuly 8, 2024 | prnewswire.comCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Down 23.7% in JuneJune 30, 2024 | marketbeat.comCASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the CompanyJune 26, 2024 | prnewswire.comCASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu HeJune 26, 2024 | prnewswire.comCASI Pharmaceuticals, Inc. (NASDAQ:CASI) Sees Significant Increase in Short InterestJune 1, 2024 | marketbeat.comCASI Pharmaceuticals, Inc. (CASI)May 26, 2024 | finance.yahoo.comCASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)May 15, 2024 | prnewswire.comCASI Pharmaceuticals, Inc.: Casi Pharmaceuticals Announces First Quarter 2024 Business And Financial ResultsMay 14, 2024 | finanznachrichten.deCASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | investorplace.comCASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTSMay 14, 2024 | prnewswire.comAnalysts Are Optimistic We'll See A Profit From CASI Pharmaceuticals, Inc. (NASDAQ:CASI)April 24, 2024 | finance.yahoo.comBioInvent International AB: Interim Report January-March 2024April 24, 2024 | finance.yahoo.comCASI Pharmaceuticals updates on Juventas disputeApril 10, 2024 | investing.comCASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTASApril 8, 2024 | finance.yahoo.com Get CASI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter. Email Address CASI Media Mentions By Week CASI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CASI News Sentiment▼0.000.57▲Average Medical News Sentiment CASI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CASI Articles This Week▼10▲CASI Articles Average Week Get CASI Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CASI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Gain Therapeutics News Today Opus Genetics News Today VistaGen Therapeutics News Today Adlai Nortye News Today ZIVO Bioscience News Today Genenta Science News Today Senti Biosciences News Today Cue Biopharma News Today PMV Pharmaceuticals News Today Connect Biopharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CASI) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CASI Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CASI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
